Startups
Sound Bioventures is a Venture Capital firm that Invests in private clinical stage biotherapeutics companies in Europe and USA. The fund has a geographic footprint on both sides of the Atlantic and will support the clinical development of novel medicines for diseases of high unmet medical need.
Overview
Location
Sweden, Malmo
Employees
1-10
Total raised
$124.37M
Founded date
2021
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 3, 2025 | In bid to improve outcomes for children with genetic bone disease, Swedish startup BOOST Pharma raises additional €3.1 million | Stockholm-based BOOST Pharma, a clinical-stage biopharmaceutical company focused on developing novel cell therapies for rare skeletal pediatric diseases, today announced that Sound Bioventures has joined its investor syndicate with a €3.1 m... |
| Sep 22, 2025 | ARTHEx Biotech: Series B Round Upsized To $87 Million For Myotonic Dystrophy Treatment Development | ARTHEx Biotech, a biotechnology company in the clinical stage of development, has recently made a significant announcement regarding its financing efforts. The company focuses on creating targeted RNA medicines, particularly for rare geneti... |
| Sep 16, 2025 | EQT Life Sciences portfolio company VarmX partners with CSL in a strategic collaboration and option agreement worth up to USD 2.2 billion | EQT Life Sciences portfolio company VarmX partners with CSL in a strategic collaboration and option agreement worth up to USD 2.2 billion Tue, Sep 16, 2025 14:00 CET Report this content VarmX is developing a bypass agent to restore coagulat... |
| Jan 11, 2025 | AnaCardio's €19 Million Leap: A New Dawn for Heart Failure Treatment | In the world of biopharmaceuticals, every funding round can feel like a heartbeat—vital and pulsating with potential. AnaCardio, a clinical-stage startup based in Stockholm, has just secured €19 million (approximately USD 19 million) to adv... |
| Jan 10, 2025 | AnaCardio pumps €19 million into heart failure treatment innovation | AnaCardio, a clinical-stage biopharmaceutical startup headquartered in Stockholm, has secured €17.8 million in a Series A extension round to develop their drug candidate AC01. The financing was co-led by Novo Holdings, Pureos Bioventures, a... |
| Jan 9, 2025 | AnaCardio raises USD 19 million to advance first-in-class drug candidate AC01 for heart failure | AnaCardio raises USD 19 million to advance first-in-class drug candidate AC01 for heart failure Thu, Jan 09, 2025 09:00 CET Report this content Reports positive results from phase 1b study of AC01 in patients with heart failure and reduced ... |
| Aug 13, 2024 | Artax Biopharma completes patient recruitment in Phase 2a trial with first-in-class Nck modulator AX-158 | AX-158 has broad potential to treat many autoimmune diseases without causing immunosuppression Psoriasis biomarker panel and PASI scores expected later this year CAMBRIDGE, Mass., Aug. 13, 2024 /PRNewswire/ -- Artax Biopharma, Inc., a clini... |
| May 25, 2023 | VarmX raises €30M to develop therapeutic proteins that restore hemostasis in bleeding patients | Leiden-based VarmX, a biotech company developing “innovative” approaches for the reversal of anticoagulation (also known as blood thinners), announced on Thursday that it has secured an additional €30M in a Series B2 round of funding. The D... |
| May 12, 2022 | Columbus VP cierra la financiación de $26M en Artax Biopharma | 12/05/2022 Nota de prensa COLUMBUS CIERRA LA FINANCIACIÓN EN LA EMPRESA ARTAX BIOPHARMA. La firma de capial riesgo (venture capital) Columbus Venture Partners cierra la financiación de 26 millones de dólares en la empresa Artax Biopharma... |
Show more
Reviews 0
FAQ about Sound Bioventures
When was Sound Bioventures founded?
Sound Bioventures was founded in 2021.
How much funding has Sound Bioventures raised?
Sound Bioventures has raised $124.37M in total across 1 funding round.
What has the press written about Sound Bioventures?
Parsers VC has collected 14 articles mentioning Sound Bioventures, among them “In bid to improve outcomes for children with genetic bone disease, Swedish startup BOOST Pharma raises additional €3.1 million” (Nov 3, 2025) and “ARTHEx Biotech: Series B Round Upsized To $87 Million For Myotonic Dystrophy Treatment Development” (Sep 22, 2025).
Is Sound Bioventures still active?
Yes, Sound Bioventures is active; its latest activity on Parsers VC dates from Oct 20, 2026.